Literature DB >> 24826919

Interconnection between brain and retinal neurodegenerations.

Vishal Jindal1.   

Abstract

The eye is a special sensory organ, which is basically an extension of the brain. Both are derived from neural tube and consist of neurons. Therefore, diseases of both the brain and eye should have some similarity. Neurodegenerative disorders like Alzheimer's disease (AD) is the major cause of dementia in the world. Amyloid deposition in the cerebral cortex and hippocampal region is the basic pathology in AD. But along with it, there are various changes that take place in the eye, i.e., abnormal pupillary reaction, decreased vision, decreased contrast sensitivity, visual field changes, loss of retinal ganglionic cells and retinal fiber layer, peripapillary atrophy, increased cup-disk ratio, retinal thinning, tortuosity of blood vessels, and deposition of Aβ-like substance in the retina. And these changes are present in the early part of the disease when only mild cognitive impairment is there. As the brain is covered by a hard bony skull which makes it difficult to directly visualize the changes occurring in the brain at molecular levels, finer details of disease progression are not available with us. But the eye is the window of the brain; with advanced modern techniques, we can directly visualize the changes in the retina at a very fine level. Therefore, by depicting neurodegenerative changes in the eye, we can diagnose and manage AD at very early stages. Along with it, retinal neurodegenerations like glaucoma and age-related macular degeneration (ARMD) are the major cause of loss of vision, and still, there are no effective treatment modalities for these blinding conditions. So if we can understand its pathogenesis and progression by correlating with brain neurodegenerations, we can come up with a better therapy for glaucoma and ARMD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24826919     DOI: 10.1007/s12035-014-8733-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  86 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Authors:  Lee E Goldstein; Julien A Muffat; Robert A Cherny; Robert D Moir; Maria H Ericsson; Xudong Huang; Christine Mavros; Jennifer A Coccia; Kyle Y Faget; Karlotta A Fitch; Colin L Masters; Rudolph E Tanzi; Leo T Chylack; Ashley I Bush
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

3.  Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).

Authors:  Shinsuke Umeda; Michihiro T Suzuki; Haru Okamoto; Fumiko Ono; Atsushi Mizota; Keiji Terao; Yasuhiro Yoshikawa; Yasuhiko Tanaka; Takeshi Iwata
Journal:  FASEB J       Date:  2005-08-12       Impact factor: 5.191

4.  Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging.

Authors:  H V Danesh-Meyer; H Birch; J Y-F Ku; S Carroll; G Gamble
Journal:  Neurology       Date:  2006-11-28       Impact factor: 9.910

5.  Expression of apoptosis markers in the retinas of human subjects with diabetes.

Authors:  Ahmed M Abu-El-Asrar; Lieve Dralands; Luc Missotten; Ibrahim A Al-Jadaan; Karel Geboes
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

Review 6.  Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma.

Authors:  Yeni H Yücel; Qiang Zhang; Robert N Weinreb; Paul L Kaufman; Neeru Gupta
Journal:  Prog Retin Eye Res       Date:  2003-07       Impact factor: 21.198

7.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

8.  Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.

Authors:  Tzvete Dentchev; Ann H Milam; Virginia M-Y Lee; John Q Trojanowski; Joshua L Dunaief
Journal:  Mol Vis       Date:  2003-05-14       Impact factor: 2.367

9.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Authors:  Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

10.  Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.

Authors:  Jaimie Hoh Kam; Eva Lenassi; Glen Jeffery
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

View more
  19 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  Sub-topographic maps for regionally enhanced analysis of visual space in the mouse retina.

Authors:  Rana N El-Danaf; Andrew D Huberman
Journal:  J Comp Neurol       Date:  2018-12-19       Impact factor: 3.215

3.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

4.  Implicating Causal Brain Magnetic Resonance Imaging in Glaucoma Using Mendelian Randomization.

Authors:  Kangcheng Liu; Pengfei Wu; Bolin Chen; Yingjun Cai; Ruolan Yuan; Jing Zou
Journal:  Front Med (Lausanne)       Date:  2022-07-01

5.  Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury.

Authors:  Abdelrahman Y Fouda; Wael Eldahshan; Zhimin Xu; Tahira Lemtalsi; Esraa Shosha; Syed Ah Zaidi; Ammar A Abdelrahman; Paul Ning-Man Cheng; S Priya Narayanan; R William Caldwell; Ruth B Caldwell
Journal:  Exp Neurol       Date:  2021-11-12       Impact factor: 5.620

6.  Functional optical coherence tomography of neurovascular coupling interactions in the retina.

Authors:  Taeyoon Son; Minhaj Alam; Devrim Toslak; Benquan Wang; Yiming Lu; Xincheng Yao
Journal:  J Biophotonics       Date:  2018-07-27       Impact factor: 3.207

7.  Age-Related Vitamin D Deficiency Is Associated with Reduced Macular Ganglion Cell Complex: A Cross-Sectional High-Definition Optical Coherence Tomography Study.

Authors:  Mathieu Uro; Olivier Beauchet; Mehdi Cherif; Alix Graffe; Dan Milea; Cedric Annweiler
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 8.  Amyloidosis in Retinal Neurodegenerative Diseases.

Authors:  Ambra Masuzzo; Virginie Dinet; Chelsea Cavanagh; Frederic Mascarelli; Slavica Krantic
Journal:  Front Neurol       Date:  2016-08-08       Impact factor: 4.003

Review 9.  Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma.

Authors:  Pawel Grieb; Anselm Jünemann; Marek Rekas; Robert Rejdak
Journal:  Front Aging Neurosci       Date:  2016-04-08       Impact factor: 5.750

10.  Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush.

Authors:  Yue Xu; Boyu Yang; Yaguang Hu; Lin Lu; Xi Lu; Jiawei Wang; Fan Xu; Shanshan Yu; Jingjing Huang; Xiaoling Liang
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.